Our team will guide you through the appropriate steps to begin safely and effectively
This literature is not intended to diagnose, treat, prevent, or cure any disease
Early clinical trials have demonstrated: Up to 24% weight loss in patients over 48 weeks Significant reduction in visceral fat as measured by MRI Improvements in insulin sensitivity and lipid profiles Unlike earlier GLP-1s, retatrutide offers broader metabolic effects by engaging multiple hormonal pathways
See a dermatologist or plastic surgeon for personalized recommendations
Just clear, honest advice
You must receive thorough, personalised instruction from your prescribing healthcare professional, GP, or a qualified nurse before attempting to inject semaglutide with a syringe yourself